Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
Part of paid clinical trials in Pittsburgh, Pennsylvania.
- Sponsor
- University of Pittsburgh
- Study ID
- NCT00260559
- Status
- Recruiting
Conditions
- Esophageal Cancer
- Esophagectomy
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Questionnaires — PROCEDUREQuality of life and heartburn assessment questionnaires are administered preoperatively and at set intervals postoperatively.
Study Details
To assess short and long term outcomes after minimally invasive esophagectomy compared to open esophagectomy. To compare both standard outcome measures as well as patient derived outcome measures, in particular, quality of life (QOL). To look at the applicability of this QOL instrument to this patient group.
Key Dates
- Start date
- May 31, 1999
- Status verified
- Mar 2026
- Primary completion
- Dec 31, 2050
- Completion
- Dec 31, 2050
Study Design
- Enrollment
- 3,500 participants (estimated)
Primary Outcome Measure
Change from baseline in SF36 Quality of Life Questionnaire at 4 month postoperative [ Time Frame: Baseline and 4 month postoperative ]
Central Contacts
- Julie A Ward, BSN412-647-8583
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Pittsburgh Medical Center - Department of Cardiothoracic Surgery | Pittsburgh | Pennsylvania | 15213 | James D. Luketich, MD (PRINCIPAL_INVESTIGATOR) Neil A. Christie, MD (SUB_INVESTIGATOR) Arjun Pennathur, MD (SUB_INVESTIGATOR) Matthew Schuchert, MD (SUB_INVESTIGATOR) Ryan Levy, MD (SUB_INVESTIGATOR) Omar Awais, DO (SUB_INVESTIGATOR) Kevin McGrath, MD (SUB_INVESTIGATOR) Tadeusz Witek, MD (SUB_INVESTIGATOR) Evan Alicuben, MD (SUB_INVESTIGATOR) Christian Otero, MD (SUB_INVESTIGATOR) Renee Levesque, MD (SUB_INVESTIGATOR) James Ackerman, MD (SUB_INVESTIGATOR) Thomas Melvin, MD (SUB_INVESTIGATOR) Navid Ajabshir, MD (SUB_INVESTIGATOR) |
| UPMC - Hillman Cancer Center | Pittsburgh | Pennsylvania | 15232 |
Find similar trials in Pittsburgh, PA
By condition
By specialty
Related Studies
- Esophageal Cancer Risk RegistryRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaPHASE1/PHASE2 · Recruiting · VM Oncology, LLC · Santa Rosa, California
- The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyRecruiting · UMC Utrecht · Pittsburgh, Pennsylvania
- A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric CancerPHASE2 · Recruiting · Memorial Sloan Kettering Cancer Center · Boston, Massachusetts